Bristol-Myers Squibb Co

Aktis Oncology Raises $72 Million From Bristol-Myers Squibb Co (NYSE:BMY) And Novartis AG (NYSE:NVS) In Series A Round For The Development Of Radiopharmaceutical Treatments

Aktis Oncology raised $72 million in Series A round from investors like Bristol-Myers Squibb Co (NYSE:BMY) and Novartis AG (NYSE: NVS). The company will use these funds for the development of Radiopharmaceutical treatments to cure solid tumors. Partial success Nuclear...

Aktis Oncology Raises $72 Million From Bristol-Myers Squibb Co (NYSE:BMY) And Novartis AG (NYSE:NVS) In Series A Round For The Development Of Radiopharmaceutical Treatments

Sample Banner Ads Below Drive Investor Traffic:

Company

Get Help